Meta-Analysis in Medicine and Health Policy
Dalene Stangl, Donald A. Berry
CRC Press, Apr 20, 2000 - Mathematics - 414 pages
This remarkable text raises the analysis of data in health sciences and policy to new heights of refinement and applicability by introducing cutting-edge meta-analysis strategies while reviewing more commonly used techniques. Each chapter builds on sound principles, develops methodologies to solve statistical problems, and presents concrete applications used by experienced medical practitioners and health policymakers. Written by more than 30 celebrated international experts, Meta-Analysis in Medicine and Health Policy employs copious examples and pictorial presentations to teach and reinforce biostatistical techniques more effectively and poses numerous open questions of medical and health policy research.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Metaanalysis of Heterogeneously Reported Study Results A Bayesian Approach
Metaanalysis versus Large Trials Resolving the Controversy
A Bayesian Metaanalysis of Randomized Megatrials for the Choice of Thrombolytic Agents in Acute Myocardial Infarction
Combining Studies with Continuous and Dichotomous Responses A LatentVariables Approach
Computermodeling and Graphical Strategies for Metaanalysis
Metaanalysis for 2 x 2 Tables with Multiple Treatment Groups
A Bayesian Metaanalysis of the Relationship between Duration of Estrogen Exposure and Occurrence of Endometrial Cancer
Metaanalysis of Population Pharmacokinetic Data
Metaanalysis of Individualpatient Survival Data Using Randomeffect Models
Adjustment for Publication Bias and Quality Bias in Bayesian Metaanalysis
Metaanalysis of Clinical Trials Opportunities and Limitations
Research Synthesis for Public Health Policy Experience of the Institute of Medicine
Metaanalysis in Practice A Critical Review of Available Software
Modeling and Implementation Issues in Bayesian Metaanalysis
Other editions - View all
allows analysis application approach assess association assume assumption average Bayes Bayesian cancer Chap choice clinical trials combining committee compared component conclusions conditional considered continuous covariates deaths decision density described discussed error estimate et al evidence example exposure factors Figure fixed fixed-effect four function given Health herbicide heterogeneity hierarchical model important included increased individual intervals Journal likelihood mean measures Medical Medicine meta-analysis methods mortality myocardial infarction normal observed obtained odds outcomes overall parameters patients plot population possible posterior posterior distribution predictive presented prior distribution probability publication bias random random-effect model rates ratio Reference regression relative reported represents Research response risk sample shows significant similar Smith specific standard Statistics studies suggest summary t-PA Table therapy tier tion treatment effect University vaccine values variability variance weighted zero
Page 103 - The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial.
Page 102 - Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343:31 1-322.
Page 147 - Rather than seeking an estimator of the classification parameters (the class parameter vectors, 0, and the class probabilities, if), we seek their full posterior probability distribution. The posterior distribution is proportional to the product of the prior distribution of the parameters p(6 , Jr | J) and the likelihood function p(x \ $,i?,J).
Page 103 - Yusuf S, Zucker D, Peduzzi P, et al: Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration.
Page 355 - Relation of soft-tissue sarcoma, malignant lymphoma and colon cancer to phenoxy acids, chlorophenols and other agents. Scand J Work Environ Health 1981; 7:119-130.
Page 230 - Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2: Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context.
Page 102 - The International Study Group: In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomized between alteplase and streptokinase with or without heparin. Lancet 1990:336:71-75.
Page 102 - The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
Page 103 - Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial: an observational study.
Page 104 - Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion GUSTO-I Investigators.